Soon-Shiong Sees T-Cell Booster as Covid Answer
Aug.19 -- Biotech billionaire Dr. Patrick Soon-Shiong, founder of ImmunityBio Inc., says just trying to block Covid with an antibody is insufficient. ImmunityBio is developing a vaccine called hAd5 that’s intended to specifically activate T-cells that scientists believe are a key part of the immune response against Covid. He speaks on "Bloomberg Markets." #California
This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.
Sharing informative videos about California.